Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
08/2012
08/02/2012US20120196934 Compositions comprising a fatty acid oil mixture comprising epa and dha in free acid form and a surfactant, and methods and uses thereof
08/02/2012US20120196929 Use of Rosmarinic Acid and the Derivaties Thereof to Treat Ciguatera
08/02/2012US20120196925 Therapeutic and Diagnostic Molecules
08/02/2012US20120196916 Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
08/02/2012US20120196903 2-aminooxazolines as taar1 ligands
08/02/2012US20120196902 Sulfoximines as kinase inhibitors
08/02/2012US20120196899 Methods and products for treating inflammation
08/02/2012US20120196896 Treatment for Oxidative Stress and/or Hypertension
08/02/2012US20120196884 Urea substituted sulphonamide derivatives
08/02/2012US20120196881 Treatment Of Pulmonary Hypertension With Carbonic Anhydrase Inhibitors
08/02/2012US20120196880 Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators
08/02/2012US20120196869 Pyrrolopyrazine-spirocyclic piperidine amides as modulators of ion channels
08/02/2012US20120196867 Composition comprising a pde4 inhibitor and a pde5 inhibitor
08/02/2012US20120196863 1,4 oxazines as bace1 and/or bace2 inhibitors
08/02/2012US20120196860 Triazine derivatives and their therapeutical applications
08/02/2012US20120196853 Novel Quinoline-Hepcidine Antagonists
08/02/2012US20120196850 ASSOCIATION OF A SINUS NODE If CURRENT INHIBITOR AND AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR, AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
08/02/2012US20120196844 Compounds and compositions as modulators of gpr119 activity
08/02/2012US20120196831 COMPOSITION FOR TREATING AND PREVENTING OBESITY INCLUDING HIGH WATER-SOLUBLE 2-HYDROXYPROPYL-betaCYCLODEXTRIN AS EFFECTIVE COMPONENT
08/02/2012US20120196830 Kits and improved compositions for treating lower urinary tract disorders
08/02/2012US20120196815 Withanolide Isolated from Physalis longifolia and Analogs and Methods of Use Thereof
08/02/2012US20120196812 Pharmaceutical composition, methods for treating and uses thereof
08/02/2012US20120196808 Peptidic Vasopressin Receptor Agonists
08/02/2012US20120196796 Amylin family peptides and methods for making and using them
08/02/2012US20120196793 Biomarkers for iap inhibitor compounds
08/02/2012US20120196789 Peptide based peroxidase inhibitors and methods of using same
08/02/2012US20120196301 Use of binding partners for 5-ht5 receptors for the treatment of neurodegenerative and neuropsychiatric disorders
08/02/2012US20120195983 Treatment of specific cardiovascular conditions with nitrite
08/02/2012US20120195976 Methods of treating inflammation by administration of heme oxygenase-1 and products of heme degradation
08/02/2012US20120195963 Highly purified ethyl epa and other epa derivatives
08/02/2012US20120195951 Therapeutic Inhibitor of Vascular Smooth Muscle Cells
08/02/2012US20120195939 Parenteral composition comprising microspheres with a diameter between 10 and 20 microns
08/02/2012US20120195934 Polymeric gel delivery system for pharmaceuticals
08/02/2012US20120195902 Compositions and methods for treating renal disease
08/02/2012US20120195901 Compositions and Methods for Binding Lysophosphatidic Acid
08/02/2012US20120195886 Sodium pump antibody agonists and methods of treating heart disease using the same
08/02/2012US20120195871 Stable aqueous suspension
08/02/2012US20120195856 Method of treating patients with cardiovascular illness
08/02/2012DE102011003315A1 New 1H-pyrazolo(3,4-b)pyridine compounds are guanylate cyclase stimulators useful for treating and/or preventing e.g. heart failure, angina pectoris, hypertonia, pulmonary hypertonia, ischemia, vascular disease, and fibrotic disorder
08/02/2012CA2825858A1 Phosphorus-containing group-substituted quinoline, its preparation process, medical composition containing the compound and application
08/02/2012CA2825716A1 Use of (s) -esmolol for controlling venous irritation associated with the treatment of a cardiac disorder
08/02/2012CA2825512A1 Radiopaque embolic particles
08/02/2012CA2825311A1 Methods of treating tachycardia and/or controlling heart rate while minimizing and/or controlling hypotension
08/01/2012EP2481738A1 Maleic acid salt and crystal thereof
08/01/2012EP2481725A1 Substituted amide compound
08/01/2012EP2481429A2 MMP Activated Vascular Disrupting Agents
08/01/2012EP2481428A2 MMP activated vascular disrupting agents
08/01/2012EP2481406A1 Use of piperphentonamine or salts thereof in manufacture of medicaments for preventing / treating brain diseases
08/01/2012EP2481399A1 Sustained drug delivery system
08/01/2012EP2481398A1 Slow-release cilostazol tablet having an improved elution rate and minimal side effects
08/01/2012EP2481298A2 Use of plant extracts as prebiotics, compostions and foods containing such extracts
08/01/2012EP2480667A1 Modulation of ttc39 expression to increase hdl
08/01/2012EP2480549A1 Fused imidazo [3, 2 - d]pyrazines as pi3 kinase inhibitors
08/01/2012EP2480548A2 Indolizine inhibitors of 5-lipoxygenase
08/01/2012EP2480547A2 Indolizine inhibitors of 5-lipoxygenase
08/01/2012EP2480538A1 [1,4]-benzodiazepines as vasopressin v2 receptor antagonists
08/01/2012EP2480536A2 Toll-like receptor modulators and uses thereof
08/01/2012EP2480526A1 Crystalline forms and processes for the preparation of pgi2 receptor agonists
08/01/2012EP2480231A2 New benzathine salts of ace inhibitors, process for their preparation and their use for the treatment of cardiovascular diseases
08/01/2012EP2480229A2 Zinc-containing compositions for the treatment of diseases, illnesses and syndromes associated with exposure to pore forming toxins
08/01/2012EP2358714B1 Alkylcyclohexylethers of dihydrotetraazabenzoazulenes
08/01/2012EP2285817B1 Novel uses of d-mannopyranose derivatives activating angiogenesis
08/01/2012EP2219625B1 Drug-containing nanoparticles comprising pioglitazone
08/01/2012EP2193793B1 Nerve cell death inhibitor
08/01/2012EP2188016B1 Use of octreotide as a therapeutic agent
08/01/2012EP2125001B1 VEGF-A or VEGF-D for use in the treatment of intra-uterine growth retardation
08/01/2012EP1848426B1 Tricyclic cytoprotective compounds
08/01/2012EP1713467B1 Compositions and methods of use of a-type procyanidins
08/01/2012EP1666472B1 Phenylacetic acid derivative, process for producing the same, and use
08/01/2012EP1531865B1 Hepatocyte growth factor (HGF) and/or insulin-like growth factor-1 (IGF-1) for use in myocardial regeneration
08/01/2012EP1432407B2 Lisinopril compositions having large-particle dcpd
08/01/2012EP1425000B1 Use of polysubstituted indan-1-ol systems for producing drugs used in the prophylaxis or treatment of obesity
08/01/2012EP1405852B1 Diamine derivatives
08/01/2012EP1389120B1 Use of nystatin for the treatment of atherosclerosis linked to the presence of parasitic fungi
08/01/2012EP1333853B1 Growth factor complex
08/01/2012EP1328653B1 Highly expressible genes
08/01/2012EP1133310B1 Artery- and vein-specific proteins and uses therefor
08/01/2012CN1993333B Triazole derivative
08/01/2012CN1534010B Water soluble extract of red sage root and its preparation method and use
08/01/2012CN102625836A Nucleic acid molecule capable of binding to HMGB1, and use thereof
08/01/2012CN102625813A Immunoglobulins with reduced aggregation
08/01/2012CN102625808A Spirocyclic amide derivatives
08/01/2012CN102625804A Compounds useful for treating AIDS
08/01/2012CN102625716A Cyclosporin conjugates
08/01/2012CN102625699A Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetate
08/01/2012CN102621243A Fingerprint spectrum of henbane medicinal material and method for controlling quality of henbane medicinal material
08/01/2012CN102618562A Neukinase, a downstream protein of neuregulin
08/01/2012CN102618424A Acanthopanax brachypus life prolonging wine
08/01/2012CN102617706A Methods for preventing mitochondrial permeability transition
08/01/2012CN102617680A Bi-functional antiplatelet aggregation medicine and application thereof
08/01/2012CN102617641A Fosinopril sodium compound and preparation method thereof
08/01/2012CN102617594A Prasugrel eutectic and preparation method, medicinal composition and application thereof
08/01/2012CN102617580A Vasopressin V1a Antagonists
08/01/2012CN102617579A Preparation method of ibudilast
08/01/2012CN102617578A Imidazole derivative and medicine application thereof
08/01/2012CN102617567A Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
08/01/2012CN102617533A Compound separated from red yeast rice, its preparation method and application
08/01/2012CN102617502A Benzoxazole derivatives and application of benzoxazole derivatives to medicines
08/01/2012CN102617462A Specificity inhibition muscle micro ribonucleic acid compound and synthesis method and application thereof
08/01/2012CN102617383A Salfaprodil crystal forms, preparation methods, and sterile powder containing salfaprodil crystals
1 ... 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 ... 1595